Projected profits were slightly more than $300,000 for the first year (from sales of $1.95 million) and were expected to increase in each of the next four years
Since Mounjaros price increase in September 2025, Wegovy 2.4 mg has often been the cheaper option, at around 150 to 250 a month privately, compared with 300 to 375 a month for Mounjaro 15 mg
Concentration (0.5%+ is ideal), stability (liposomal delivery beats plain formulas), and complementary ingredients (vitamin C, niacinamide) make or break results
Related Research Compounds The KLOW blend peptide is studied alongside other regenerative and recovery research peptide blends
Medicare coverage and eligibility rules are subject to change
This inconsistency may have contributed to the observed heterogeneity